221 related articles for article (PubMed ID: 24641494)
1. Inhibition of PKC-θ preserves cardiac function and reduces fibrosis in streptozotocin-induced diabetic cardiomyopathy.
Li Z; Abdullah CS; Jin ZQ
Br J Pharmacol; 2014 Jun; 171(11):2913-24. PubMed ID: 24641494
[TBL] [Abstract][Full Text] [Related]
2. Depletion of T lymphocytes ameliorates cardiac fibrosis in streptozotocin-induced diabetic cardiomyopathy.
Abdullah CS; Li Z; Wang X; Jin ZQ
Int Immunopharmacol; 2016 Oct; 39():251-264. PubMed ID: 27494688
[TBL] [Abstract][Full Text] [Related]
3. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein kinase C β ameliorates impaired angiogenesis in type I diabetic mice complicating myocardial infarction.
Ikeda A; Matsushita S; Sakakibara Y
Circ J; 2012; 76(4):943-9. PubMed ID: 22313801
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
[TBL] [Abstract][Full Text] [Related]
6. Diacylglycerol kinase zeta inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus.
Bilim O; Takeishi Y; Kitahara T; Arimoto T; Niizeki T; Sasaki T; Goto K; Kubota I
Cardiovasc Diabetol; 2008 Feb; 7():2. PubMed ID: 18241357
[TBL] [Abstract][Full Text] [Related]
7. A critical role for protein kinase C-theta-mediated T cell survival in cardiac allograft rejection.
Manicassamy S; Yin D; Zhang Z; Molinero LL; Alegre ML; Sun Z
J Immunol; 2008 Jul; 181(1):513-20. PubMed ID: 18566417
[TBL] [Abstract][Full Text] [Related]
8. Forskolin Protected against Streptozotocin-Induced Diabetic Cardiomyopathy via Inhibition of Oxidative Stress and Cardiac Fibrosis in Mice.
Zhang X; Ke PX; Yuan X; Zhang GP; Chen WL; Zhang GS
Biomed Res Int; 2021; 2021():8881843. PubMed ID: 33564685
[TBL] [Abstract][Full Text] [Related]
9. Targeted deletion of T-cell S1P receptor 1 ameliorates cardiac fibrosis in streptozotocin-induced diabetic mice.
Abdullah CS; Jin ZQ
FASEB J; 2018 Oct; 32(10):5426-5435. PubMed ID: 29698062
[TBL] [Abstract][Full Text] [Related]
10. Lack of osteopontin improves cardiac function in streptozotocin-induced diabetic mice.
Subramanian V; Krishnamurthy P; Singh K; Singh M
Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H673-83. PubMed ID: 16980342
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy.
Connelly KA; Kelly DJ; Zhang Y; Prior DL; Advani A; Cox AJ; Thai K; Krum H; Gilbert RE
Circ Heart Fail; 2009 Mar; 2(2):129-37. PubMed ID: 19808328
[TBL] [Abstract][Full Text] [Related]
12. Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.
Elmarakby AA; Faulkner J; Al-Shabrawey M; Wang MH; Maddipati KR; Imig JD
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1307-17. PubMed ID: 21832210
[TBL] [Abstract][Full Text] [Related]
13. Connexin43 and zonula occludens-1 are targets of Akt in cardiomyocytes that correlate with cardiac contractile dysfunction in Akt deficient hearts.
Ock S; Lee WS; Kim HM; Park KS; Kim YK; Kook H; Park WJ; Lee TJ; Abel ED; Kim J
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1183-1191. PubMed ID: 29378301
[TBL] [Abstract][Full Text] [Related]
14. Improvement in cardiac function of diabetic rats by bosentan is not associated with changes in the activation of PKC isoforms.
Jiang J; Yuen V; Xiang H; McNeill JH
Mol Cell Biochem; 2006 Jan; 282(1-2):177-85. PubMed ID: 16317525
[TBL] [Abstract][Full Text] [Related]
15. Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes.
Li Y; Ma J; Zhu H; Singh M; Hill D; Greer PA; Arnold JM; Abel ED; Peng T
Diabetes; 2011 Nov; 60(11):2985-94. PubMed ID: 21911754
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of 14-3-3 protein exacerbates cardiac hypertrophy and fibrosis through enhanced expression of protein kinase C beta 2 in experimental diabetes.
Gurusamy N; Watanabe K; Ma M; Zhang S; Muslin AJ; Kodama M; Aizawa Y
Biol Pharm Bull; 2005 Jun; 28(6):957-62. PubMed ID: 15930726
[TBL] [Abstract][Full Text] [Related]
17. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression.
Wang Y; Zhou S; Sun W; McClung K; Pan Y; Liang G; Tan Y; Zhao Y; Liu Q; Sun J; Cai L
Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1239-47. PubMed ID: 24714399
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein Preserves Akt2 Activity and Cardiac Function via Inhibiting TRB3 in Diabetic Hearts.
Gu J; Yan X; Dai X; Wang Y; Lin Q; Xiao J; Zhou S; Zhang J; Wang K; Zeng J; Xin Y; Barati MT; Zhang C; Bai Y; Li Y; Epstein PN; Wintergerst KA; Li X; Tan Y; Cai L
Diabetes; 2018 Mar; 67(3):507-517. PubMed ID: 29079702
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach.
Liu Q; Chen X; Macdonnell SM; Kranias EG; Lorenz JN; Leitges M; Houser SR; Molkentin JD
Circ Res; 2009 Jul; 105(2):194-200. PubMed ID: 19556521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
